Skip to main content
Premium Trial:

Request an Annual Quote

Personalized Medicine's Starts and Fits

Personalized medicine, says this article in The Scientist, could breathe new life into failed drug candidates. "If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market," Personalized Medicine Coalition's Edward Abrahams says. "'Failed' just means it failed in a percent of the population." And as Francis Collins settles in as the head of NIH, the article adds, many expect that personalized medicine will move to the top of the to-do list

In an accompanying editorial, Richard Gallagher writes that "we've stumbled forward a little on the road to personalized medicine, but it looks like the pace towards Nirvana is about to pick up."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.